VIVEX Biologics
PrivateLast Round
Debt
Apr 6, 2017
Total Funding Raised
$23.2M
Company Overview
VIVEX Biologics is a regenerative medicine company that develops and delivers innovative allografts for orthopedic, spine, wound care, and pain management applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIVEX Biologics Comparables
Compare VIVEX Biologics with similar companies based on industry and business-model similarity.
VIVEX Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 6, 2017 | ||||
| Series A | Jan 6, 2016 | ||||
| Private Equity | Sep 18, 2013 |
VIVEX Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAM Capital Partners | Private Equity |
| Ellis Capital | Private Equity |
VIVEX Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VIVEX Biologics's valuation, stock price, and market status.